510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K060354Substantially Equivalent

Acro Biotech Llc Rapid Benzodiazepine Urine Test, Catalog Bzd001000

ACRO BIOTECH Inc., Rancho Cucamonga CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K060354 is the FDA 510(k) clearance record for ACRO BIOTECH LLC RAPID BENZODIAZEPINE URINE TEST, CATALOG BZD001000, a class II device, cleared for Acro Biotech, LLC on under FDA product code JXM (Enzyme Immunoassay, Benzodiazepine). FDA records list 10 510(k) clearances for Acro Biotech, LLC, from to . As of , FDA records show no recalls naming K060354.

Clearance record

Decision date
Received
(165 days to decision)
Product code
JXM Enzyme Immunoassay, Benzodiazepine
Regulation
21 CFR 862.3170
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Acro Biotech, LLC 9500 7th St. Unit M, Rancho Cucamonga CA
510(k) summary
Statement
Third party review
No

Clearances, product code JXM

Trailing 12 months

FDA records hold no clearances under product code JXM in the trailing twelve months.

FDA records show no clearances under product code JXM in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JXM, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260